Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
A possibility to diminish the number of recurrences in chronic pancreatitis by using delagil (chloroquine) was shown during investigation of the status of cell-mediated immunity in chronic pancreatitis. The paper is concerned with the results of the determination of the ratio of theophylline-resistant T-cells (helpers) to theophylline-sensitive T-cells (suppressors) in the peripheral blood. The H/S ratio was determined in 49 patients with different patterns of chronic pancreatitis and in 20 controls. Enhanced (greater than or equal to 5) and low (less than or equal to 1.5) indices were characteristics of an unfavorable course of the disease. The H/S ratio is recommended for clinical use in pancreatology for prognostic purposes and to define the need of immune modifying therapy.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!